Hubei Vanz Pharm Co.,ltd.

 

warrantable quality,trustable service!

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
News
Home ProductsPharmaceutical Raw Materials

Antineoplastic Agents Pharmaceutical Raw Materials AZD9291 CAS 1421373-65-0

I'm Online Chat Now
China Hubei Vanz Pharm Co.,ltd certification
China Hubei Vanz Pharm Co.,ltd certification
I am very happy to cooperate with your company for nearly three years, thank you very attentive service, thank you for the excellent product quality.

—— Stephnie

You always have very fast delivery, very happy to cooperate with you. Thank you.

—— John

Very pleased to become your customer, and very happy for our cooperation, hope to be your long-term parter.

—— Sara

we received the package, very fast, the quality is very good, will continue to buy your products.

—— Luice

I have emailed you a couple times and they get returned as undeliverable. Yes. I am happy with the powders. thank you.

—— Bryan

Antineoplastic Agents Pharmaceutical Raw Materials AZD9291 CAS 1421373-65-0

Antineoplastic Agents Pharmaceutical Raw Materials AZD9291 CAS 1421373-65-0
Antineoplastic Agents Pharmaceutical Raw Materials AZD9291 CAS 1421373-65-0 Antineoplastic Agents Pharmaceutical Raw Materials AZD9291 CAS 1421373-65-0

Large Image :  Antineoplastic Agents Pharmaceutical Raw Materials AZD9291 CAS 1421373-65-0 Get Best Price

Product Details:

Place of Origin: CHINA MAINLAND
Brand Name: VANZ
Certification: COA
Model Number: MEDICINE GRADE

Payment & Shipping Terms:

Minimum Order Quantity: 100GRAMS
Packaging Details: IN ALUMINIUM OR DEPEND ON CLIENTS REQUIREMENTS
Delivery Time: 3DAYS AFTER PAID
Payment Terms: T/T, Western Union, MoneyGram
Detailed Product Description
PURITY: 99% APPEARANCE: PALE YELLOW POWDER
MF: C28H33N7O2 MP: 228-230 °C
BP: 614.3 °C At 760 MmHg CAS NO.: 1421373-65-0
High Light:

Pharma Raw Materials

,

raw pharmaceutical materials

Antineoplastic Agents Pharmaceutical Raw Materials AZD9291 CAS 1421373-65-0

 

Product details:

 

AZD9291  a third-generation orally irreversible epidermal growth factor receptor (EGFR) inhibitor, is under development by British drug maker AstraZeneca for the treatment of patients with metastatic EGFR T790M mutation-positive non-small cell lung cancer (NSCLC).

 

 

Biological Activity:

AZD-9291 is an irreversible inhibitor of mutant EGFR kinase with IC50 values of 15nM, 17nM and 480nM, respectively for L858R/T790M, ex19del and wild-type EGFR.

 

Purity:99%min

Singel impurity:0.1%max

 

Related products:

 

Tofacitinib Citrate CAS NO.540737-29-9
Posaconazole CAS NO.171228-49-2
ramelteon CAS NO.196597-26-9
sofosbuvir CAS NO.1190307-88-0
daclatasvir CAS NO.1009119-65-6
ledipasvir CAS NO.1256388-51-8
asunaprevir CAS NO.630421-48-6
vorapaxar CAS NO.618385-01-6
vildagliptin CAS NO.274901-16-5

 

Antineoplastic Agents Pharmaceutical Raw Materials AZD9291 CAS 1421373-65-0 0

 

Contact Details
Hubei Vanz Pharm Co.,ltd

Contact Person: Ms. Wendy Wang

Tel: +86 15927784577

Fax: 86-27-84492310

Send your inquiry directly to us